The U.S. Federal Trade Commission said on Tuesday it will sue to block the $4 billion merger between mattress manufacturer Tempur Sealy International Inc and retailer Mattress Firm. Tempur Sealy had announced the cash-and-stock deal in May 2023,
But the FTC said Tuesday in its release that the acquisition would create "enormous power" at multiple parts of the mattress supply chain. WASHINGTON — Inflation in the U.S. is slowing again after higher readings earlier this year,
A closely-watched lawsuit seeking to block Tempur Sealy’s $4.3 billion acquisition of retail giant Mattress Firm will pit veteran antitrust defenders against a U.S. Federal Trade Commission team led by a former longtime Latham & Watkins attorney who joined the agency this year.
The Federal Trade Commission voted unanimously Tuesday to block mattress supplier Tempur Sealy International from acquiring retailer Mattress Firm in a $4 billion deal over concerns the combined business would suppress competition and send prices soaring.
Vizio (NYSE:VZIO), which agreed to sell itself to Walmart (WMT) in February, edged lower by 1.2% as the Federal Trade Commission sued to block Tempur Sealy's (TPX) sale to Mattress Firm. Earlier Tuesday,
The U.S. Federal Trade Commission is preparing to sue to block the $4 billion merger between mattress manufacturer Tempur Sealy International Inc and retailer Mattress Firm, a source familiar with the matter said on Tuesday.
Tempur Sealy International (NYSE:TPX) provided a statement to Seeking Alpha regarding the Federal Trade Commission challenging the proposed merger of the company with Mattress Firm Group Inc. "Tempur Sealy has been working constructively with the FTC to secure regulatory approval for this transaction and is disappointed that the FTC has initiated
The Federal Trade Commission is poised to sue to block mattress maker Tempur Sealy's (NYSE:TPX) $4 billion planned purchase of retailer Mattress Firm. Tempur Sealy ticked lower by 0.5% in premarket trading.
FTC sues to block Tempur Sealy's $4B purchase of Mattress Firm. EV maker Rivian has no production plans with Volkswagen - report. Eli Lilly wins FDA approval of donanemab for Alzheimer's.